Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2016 Jun 30;17(1):305.
doi: 10.1186/s13063-016-1432-z.

Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial

Affiliations
Randomized Controlled Trial

Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial

Yuxiu Sun et al. Trials. .

Abstract

Background: Many previous studies have shown the potential therapeutic effect of acupuncture for allergic rhinitis. Most of these studies, however, were limited by the short duration of observations and lack of sham acupuncture as the control group. Our preliminary experiments showed that the use of a warm needling achieved a much more persistent effect in the treatment of allergic rhinitis (AR) compared with simple acupuncture therapy. Hence, we have designed a multicenter, randomized controlled trial (RCT) in which the first-line medication loratadine will be used as the control group, and the effect of warm needling therapy will be evaluated through long-term observation.

Methods/design: The trial is designed as a multicenter, parallel-group, randomized, single-blinded (outcome assessors), non-inferiority trial. A total of 98 patients with persistent AR will be randomly assigned into two groups. Patients in the treatment group will be treated with warm needling at GV14 and acupuncture at EX-HN3, ST2, LI20, EX-HN8, GV23, LU7, LU5 and LI4 three times a week, for a total of 4 weeks. Patients in the control group will be treated with oral loratadine 10 mg/day for 4 weeks. The primary outcome will be the change in the Total Nasal Symptom Score (TNSS) from baseline to that at 6 months after treatment during the follow-up period. The secondary outcomes will include the Total Non-nasal Symptom Score and the Rhinoconjunctivitis Quality of Life Questionnaire, changes in the TNSS from baseline to that at 2 and 4 weeks during treatment, and 3 months after treatment during the follow-up period. Outcomes will be measured at 2 and 4 weeks, and 3 and 6 months after treatment. Any side effects of treatment will be observed and recorded.

Discussion: We expect that the study results will provide evidence to determine the effects of warm needling compared with loratadine. Our final goal of the study is to evaluate the difference in the short-term and long-term effects between the two therapeutic methods, especially the long-term effect of warm needling.

Trial registration: ClinicalTrials.gov NCT02339714 . Registered on 14 January 2015.

Keywords: Acupuncture; Persistent allergic rhinitis; RCT; Study protocol; Warm needling.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Flowchart of the study design
Fig. 2
Fig. 2
The total study period and the evaluation time points

Similar articles

Cited by

References

    1. Bousquet J, Van CP, Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(Suppl 5):147–334. doi: 10.1067/mai.2001.118891. - DOI - PubMed
    1. Bousquet J, Khaltaev N, Cruz AA, Denburg J, Fokkens WJ, Togias A, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update. Allergy. 2008;63(Suppl 86):8–160. doi: 10.1111/j.1398-9995.2007.01620.x. - DOI - PubMed
    1. Bousquet PJ, Leynaert B, Neukirch F, Sunyer J, Janson CM, Anto J, et al. Geographical distribution of atopic rhinitis in the European Community Respiratory Health Survey. Allergy. 2008;63:1301–9. doi: 10.1111/j.1398-9995.2008.01824.x. - DOI - PubMed
    1. Han DM, Zhang L, Huang D, Wu YF, Dong Z, Xu G, et al. Self-reported prevalence of allergic rhinitis in eleven cities in China. Chin J Otorhinolaryngol Head Neck Surg. 2007;42:378–84. - PubMed
    1. Zheng M, Wang XD, Bo MY, Wang KJ, Zhao Y, He F, et al. Prevalence of allergic rhinitis among adults in urban and rural areas of China: a population-based cross-sectional survey. Allergy Asthma Immunol Res. 2015;7:148–57. doi: 10.4168/aair.2015.7.2.148. - DOI - PMC - PubMed

MeSH terms

Associated data